Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:22 PM
Ignite Modification Date:
2025-12-24 @ 10:22 PM
NCT ID:
NCT04135235
Eligibility Criteria:
Inclusion Criteria:
* No nucleoside analog antiviral drugs have been used in the past.
* HBsAg and HBeAg double positive, HBV DNA\>106 IU/mL.
* Fully inform the risk to voluntarily join the study and sign the informed consent form.
Exclusion Criteria:
* Combine other viral infections: such as HCV, HIV, CMV, etc.;
* amniocentesis during pregnancy;
* Liver cirrhosis and liver cancer;
* Other autoimmune diseases and liver diseases;
* fetal ultrasound screening in early and middle pregnancy found deformity.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT04135235
Study Brief:
Protocol Section:
NCT04135235